{{refimprove|date=June 2016}}
{{Drugbox
| Watchedfields = changed
| verifiedrevid = 476999776
| IUPAC_name = 6-aminohexanoic acid
| image = 6-Aminocaproic acid.png
| image2 = Aminocaproic acid ball-and-stick.png
<!--Clinical data-->
| tradename =  Amicar
| Drugs.com = {{drugs.com|monograph|aminocaproic_acid}}
| MedlinePlus = a608023
| pregnancy_category =  
| legal_status = Rx-only
| routes_of_administration =  
<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism = [[Renal]]
| elimination_half-life = 2 hours
<!--Identifiers-->
| IUPHAR_ligand = 6574
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 60-32-2
| ATC_prefix = B02
| ATC_suffix = AA01
| ATC_supplemental =  
| PubChem = 564
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB00513
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 548
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = U6F3787206
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D00160
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 16586
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 1046
| NIAID_ChemDB = 018631
<!--Chemical data-->
| C=6 | H=13
| N=1 | O=2
| molecular_weight = 131.173 g/mol
| smiles = C(CCC(=O)O)CCN
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C6H13NO2/c7-5-3-1-2-4-6(8)9/h1-5,7H2,(H,8,9)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = SLXKOJJOQWFEFD-UHFFFAOYSA-N
| melting_point = 205
}}

'''Aminocaproic acid''' (also known as '''ε-aminocaproic acid''', '''ε-Ahx''', or '''6-aminohexanoic acid''') is a derivative and analogue of the [[amino acid]] [[lysine]], which makes it an effective [[enzyme inhibitor|inhibitor]] for [[enzyme]]s that bind that particular residue. Such enzymes include [[proteolytic]] enzymes like [[plasmin]], the enzyme responsible for [[fibrinolysis]]. For this reason it is effective in treatment of certain [[coagulopathy|bleeding disorders]], and it is marketed as '''Amicar'''. Aminocaproic acid is also an intermediate in the polymerization of Nylon-6, where it is formed by ring-opening hydrolysis of [[caprolactam]].

==Medical use==
Aminocaproic acid (Amicar) is FDA-approved for use in the treatment of acute bleeding due to elevated fibrinolytic activity.<ref>Amicar[R] [FDA label]. <nowiki>http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/15197scm036,scf037,scp038,scm039_amicar_lbl.pdf</nowiki>. Accessed August 20, 2016
</ref> It also carries an Orphan Drug designation from the FDA for the prevention of recurrent hemorrhage in patients with traumatic hyphema.<ref>Food and Drug Administration. Orphan designations pursuant to section 526 of the Federal Food and Cosmetic Act as amended by the Orphan Drug Act (P.L. 97-414) to June 28, 1996. Rockville, MD; 1996 Jul.</ref>
In clinical practice, aminocaproic acid is frequently used off-label for control of bleeding in patients with severe thrombocytopenia,<ref>{{Cite journal|last=Bartholomew JR|last2=Salgia R|last3=Bell WR|date=1989-09-01|title=Control of bleeding in patients with immune and nonimmune thrombocytopenia with aminocaproic acid|url=https://dx.doi.org/10.1001/archinte.1989.00390090039008|journal=Archives of Internal Medicine|volume=149|issue=9|pages=1959–1961|doi=10.1001/archinte.1989.00390090039008|issn=0003-9926}}</ref> control of oral bleeding in patients with congenital and acquired coagulation disorders,<ref>{{Cite journal|last=Lucas|first=O. N.|last2=Albert|first2=T. W.|date=1981-02-01|title=Epsilon aminocaproic acid in hemophiliacs undergoing dental extractions: a concise review|url=http://www.ncbi.nlm.nih.gov/pubmed/?term=6782532|journal=Oral Surgery, Oral Medicine, and Oral Pathology|volume=51|issue=2|pages=115–120|issn=0030-4220|pmid=6782532}}</ref> control of perioperative bleeding associated with cardiac surgery,<ref>{{Cite journal|last=Lu|first=Jun|last2=Meng|first2=Haoyu|last3=Meng|first3=Zhaoyi|last4=Sun|first4=Ying|last5=Pribis|first5=John P.|last6=Zhu|first6=Chunyan|last7=Li|first7=Quan|date=2015-01-01|title=Epsilon aminocaproic acid reduces blood transfusion and improves the coagulation test after pediatric open-heart surgery: a meta-analysis of 5 clinical trials|journal=International Journal of Clinical and Experimental Pathology|volume=8|issue=7|pages=7978–7987|issn=1936-2625|pmc=4555692|pmid=26339364}}</ref><ref>{{Cite journal|last=Chen|first=R. H.|last2=Frazier|first2=O. H.|last3=Cooley|first3=D. A.|date=1995-01-01|title=Antifibrinolytic therapy in cardiac surgery|journal=Texas Heart Institute Journal|volume=22|issue=3|pages=211–215|issn=0730-2347|pmc=325256|pmid=7580358}}</ref> prevention of excessive bleeding in patients on anticoagulation therapy undergoing invasive dental procedures,<ref>{{Cite journal|last=Patatanian|first=Edna|last2=Fugate|first2=Susan E.|date=2006-12-01|title=Hemostatic mouthwashes in anticoagulated patients undergoing dental extraction.|journal=The Annals of Pharmacotherapy|volume=40|issue=12|pages=2205–2210|doi=10.1345/aph.1H295|issn=1542-6270|pmid=17090725}}</ref> and reduction of the risk of catastrophic hemorrhage in patients with acute promyelocytic leukemia.<ref>{{Cite journal|last=Wassenaar|first=T.|last2=Black|first2=J.|last3=Kahl|first3=B.|last4=Schwartz|first4=B.|last5=Longo|first5=W.|last6=Mosher|first6=D.|last7=Williams|first7=E.|date=2008-12-01|title=Acute promyelocytic leukaemia and acquired α-2-plasmin inhibitor deficiency: a retrospective look at the use of epsilon-aminocaproic acid (Amicar) in 30 patients|url=http://onlinelibrary.wiley.com/doi/10.1002/hon.867/abstract|journal=Hematological Oncology|language=en|volume=26|issue=4|pages=241–246|doi=10.1002/hon.867|issn=1099-1069|pmc=3496178|pmid=18613223}}</ref>

== References ==
{{Reflist}}

== Further reading ==
* {{cite journal | vauthors = Alkjaersig N, Fletcher AP, Sherry S | title = xi-Aminocaproic acid: an inhibitor of plasminogen activation | journal = The Journal of Biological Chemistry | volume = 234 | issue = 4 | pages = 832–7 | date = April 1959 | pmid = 13654273 }}
* {{cite journal | vauthors = Kang Y, Lewis JH, Navalgund A, Russell MW, Bontempo FA, Niren LS, Starzl TE | title = Epsilon-aminocaproic acid for treatment of fibrinolysis during liver transplantation | journal = Anesthesiology | volume = 66 | issue = 6 | pages = 766–73 | date = June 1987 | pmid = 3296855 | pmc = 2965586 | doi = 10.1097/00000542-198706000-00010 }}

{{Antihemorrhagics}}

[[Category:Amino acids]]
[[Category:Antifibrinolytics]]